These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 11066971)

  • 21. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seeking value in working with pharmacy benefit managers.
    Vogenberg FR; Sica JM
    Benefits Q; 2003; 19(1):7-12. PubMed ID: 12608113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial resistance: a deadly burden no country can afford to ignore.
    Birnbaum D;
    Can Commun Dis Rep; 2003 Sep; 29(18):157-64. PubMed ID: 14524197
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug utilization decisions should be based on cost-benefit data].
    Bengt J; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
    [No Abstract]   [Full Text] [Related]  

  • 25. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing costs. Braking point.
    Reid E; Cooke J; Johnson R; McKnight H
    Health Serv J; 2000 May; 110(5705):28-30. PubMed ID: 11183327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of pharmaceuticals--some direction for employers.
    Goetzel RZ; Ozminkowski RJ; Schutt DC
    Empl Benefits J; 2002 Sep; 27(3):31-5. PubMed ID: 12219561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription medicines: the costs, the benefits, and the promise.
    Ingram RA
    N C Med J; 2003; 64(6):275-7. PubMed ID: 14983615
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacoeconomics in the era of individualized medicine.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2008 Aug; 84(2):179-82. PubMed ID: 18679176
    [No Abstract]   [Full Text] [Related]  

  • 31. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.
    Fendrick AM; Smith DG; Chernew ME; Shah SN
    Am J Manag Care; 2001 Sep; 7(9):861-7. PubMed ID: 11570020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintaining a mission. Medicaid plans focus on pharmaceutical care.
    Gearon CJ
    Healthplan; 2002; 43(4):54-6. PubMed ID: 12221779
    [No Abstract]   [Full Text] [Related]  

  • 33. Medicare cost containment strategy targets several oncology drugs.
    Twombly R
    J Natl Cancer Inst; 2004 Sep; 96(17):1268-70. PubMed ID: 15339960
    [No Abstract]   [Full Text] [Related]  

  • 34. Bringing the DERP to consumers: 'Consumer Reports Best Buy Drugs'.
    Findlay SD
    Health Aff (Millwood); 2006; 25(4):W283-6. PubMed ID: 16757490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The true cost and benefit of medication reduction.
    Aurigemma R
    Del Med J; 2009 Apr; 81(4):163-4. PubMed ID: 19552220
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
    Kocs D; Fendrick AM
    Am J Manag Care; 2003 May; 9(5):393-400; quiz 401-2. PubMed ID: 12744301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bold approach curtails bronchitis antibiotic use.
    Clin Resour Manag; 2001 Jan; 2(1):1-6. PubMed ID: 11215352
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of cost-effectiveness analysis to guide the clinical implementation of new therapies].
    Borrás Pérez FX
    Rev Esp Cardiol; 2005 Dec; 58(12):1377-80. PubMed ID: 16371195
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacy carve-out offers cost control, computer modeling.
    Capitation Manag Rep; 2002 Jul; 9(7):103-8, 97. PubMed ID: 12164058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment.
    Sheehan DV; Wright-Etter PJ
    Manag Care Q; 2002; 10(3):21-31. PubMed ID: 12476662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.